Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative
US9034876B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9034876-B2 |
| Application number | US-201313911465-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 6, 2013 |
| Priority date | Dec 6, 2010 |
| Publication date | May 19, 2015 |
| Grant date | May 19, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This application describes and provides a method of treating diseases or disorders characterized by chronic systemic inflammation, such as rheumatoid arthritis, using a compound that inhibits JAK2 kinase.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating rheumatoid arthritis comprising: identifying a subject affected by rheumatoid arthritis, and administering to said subject a therapeutically effective amount of Compound A: or a salt thereof. 2. A method of treating chronic systemic inflammation comprising: identifying a subject affected by chroni…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9034876B2 cover?
- This application describes and provides a method of treating diseases or disorders characterized by chronic systemic inflammation, such as rheumatoid arthritis, using a compound that inhibits JAK2 kinase.
- Who is the assignee on this patent?
- Cephalon Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/496. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).